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Abstract  Anti-N-methyl-d-aspartate  receptor  encephalitis  is  a  recently  described  neurological
disorder  and  an  increasingly  recognized  cause  of  psychosis,  movement  disorders  and  autonomic
dysfunction.  We  report  20-year-old  Chinese  female  who  presented  with  generalized  tonic--clonic
seizures, recent  memory  loss,  visual  hallucinations  and  abnormal  behavior.  Anti-N-methyl-d-
aspartate  receptor  encephalitis  was  diagnosed  and  a  computed  tomography  scan  of  abdomen
reviewed  a  left  adnexal  tumor.  We  describe  the  ﬁrst  such  case  report  of  a  patient  with  anti-N-
methyl-d-aspartate  receptor  encephalitis  who  was  given  a  bilateral  transversus  abdominis  plane
block as  the  sole  anesthetic  for  removal  of  ovarian  tumor.  We  also  discuss  the  anesthetic  issues
associated with  anti-N-methyl-d-aspartate  receptor  encephalitis.  As  discovery  of  tumor  and  its
removal is  the  focus  of  initial  treatment  in  this  group  of  patients,  anesthetists  will  encounter
more such  cases  in  the  near  future.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an





Anestesia  em  encefalite  antirreceptor  de  N-metil-d-aspartato  --  a  anestesia  geral  é
um  requisito?  Relato  de  caso
Resumo  A  encefalite  antirreceptor  de  N-metil-d-aspartato  (NMDA)  é  um  distúrbio  neurológico
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NMDA  e  anestesia
movimento  e  disfunc¸ão  autonômica.  Relatamos  o  caso  de  uma  paciente  de  origem  Chinesa,  20
anos de  idade,  que  se  apresentou  com  crises  tônico-clônicas  generalizadas,  perda  de  memória
recente, alucinac¸ões  visuais  e  comportamento  anormal.  Encefalite  antirreceptor  de  NMDA  foi
diagnosticada  e  uma  tomograﬁa  computadorizada  de  abdome  revelou  um  tumor  anexial  à
esquerda.  Descrevemos  o  primeiro  relato  de  caso  de  paciente  com  encefalite  antirreceptor
de NMDA  submetida  ao  bloqueio  de  plano  transverso  abdominal  (PTA)  bilateral  como  única
anestesia  para  remoc¸ão  de  tumor  ovariano.  Também  discutimos  as  questões  anestésicas  associ-
adas à  encefalite  antirreceptor  de  NMDA.  Como  a  descoberta  e  a  remoc¸ão  do  tumor  são  o  foco
do tratamento  inicial  nesse  grupo  de  pacientes,  os  anestesiologistas  encontrarão  mais  desses
casos no  futuro  próximo.
©  2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um



































































nti-N-methyl-d-aspartate  (NMDA)  receptor  encephalitis
as  ﬁrst  described  in  2007.1 Although  more  than  400  cases
ave  since  been  diagnosed,  literature  regarding  anesthetic
anagement  is  scarce,  with  only  3  cases  reported  in  recent
ears.2--4 This  is  surprising  because  most  patients  will  need
nesthesia  for  removal  of  tumor.  Clinicians  have  to  be  aware
hat  the  pathology  of  this  speciﬁc  encephalitis  is  likely  to
ffect  the  actions  of  many  drugs  that  act  upon  the  NMDA
eceptor.
We  describe  the  ﬁrst  such  case  report  of  a  patient  with
nti-NMDA  receptor  encephalitis  who  was  given  a  bilateral
ransversus  abdominis  plane  (TAP)  block  as  the  sole  anes-
hetic  for  removal  of  ovarian  tumor.
ase presentation
 previously  well  20-year-old  female  presented  with  sud-
en  onset  of  generalized  tonic--clonic  seizures  which  was
receded  by  recent  memory  loss,  visual  hallucinations  and
bnormal  behavior.  She  was  afebrile  and  haemodynamically
table.  Her  white  cell  count,  MRI  brain  and  lumbar  punc-
ure  were  normal  and  electroencephalogram  showed  slow
ackground  activity.  She  was  treated  as  a  case  of  asep-
ic  meningitis  with  intravenous  acyclovir  and  antiepileptics.
fter  one  week  she  was  referred  to  our  institution  for  further
anagement.
In  our  institution,  she  was  given  intravenous  methylpred-
isolone  for  ﬁve  days  while  being  continued  on  intravenous
cyclovir,  lamotrigine  and  risperidone.  Her  behavioral
bnormalities  and  seizures  persisted.  Her  serum  was  tested
y  indirect  immunoﬂuorescent  antibody  test  (Luebeck,  Ger-
any)  and  was  positive  for  antibodies  against  the  NMDA
eceptor  (Speciﬁcity  100%).  Abdominal  CT  scan  revealed  a
 cm  ×  4  cm  ×  4  cm  left  adnexal  mass,  likely  to  be  an  ovarianPlease  cite  this  article  in  press  as:  Chaw  SH,  et  al.  Anesthesi
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eratoma.
She  was  scheduled  for  laparotomy  and  cystectomy.
egional  anesthesia  with  a  bilateral  TAP  block  was  planned




cPreoperatively,  she  was  unable  to  follow  commands  and
howed  abnormal  behaviors  such  as  inappropriate  laugh-
ng  and  jerking  movements.  Baseline  blood  pressure  was
40/95  mmHg,  heart  rate  115  beats  per  minute  (bpm)  and
aturations  98%  on  oxygen  3  L/min.
In  theater,  under  standard  monitoring,  ultrasound-guided
Sonosite  M-turboTM, Sonosite  Inc.,  Bothell,  WA,  USA)  bilat-
ral  TAP  block  was  done.  A  linear  probe  13--6  MHz  was
laced  at  the  lateral  abdominal  wall  in  the  midaxillary  line,
etween  the  subcostal  margin  and  iliac  crest.  A  21G,  80  mm
nsulated  needle  (StimuplexTM A,  B.Braun,  Melsungen  AG,
elsungen,  Germany)  was  directed  to  the  TAP  using  in-plane
echnique.  Twenty  millilitres  of  levo-bupivacaine  0.25%  was
njected  into  the  transversus  abdominis  fascial  plane  on  each
ide.
After  15  min,  the  adequacy  of  block  was  assessed.  As  the
atient  was  unable  to  follow  commands,  we  relied  on  her
acial  expressions,  movement  and  sympathetic  responses
uch  as  heart  rate.  Surgery  started  when  there  was  no
esponse  to  pin  prick  up  to  T8  dermatomal  level.
A  Pfennensteil  incision  was  made,  followed  by  excision  of
he  tumor.  Fentanyl  25  mcgs  was  administered  intravenously
s  supplement  for  visceral  pain.  Intraoperatively  she  was
table  with  blood  pressure  of  110/75--140/95  mmHg,  heart
ate  100--115  bpm,  respiratory  rate  18--20  per  minute  and
aturations  99--100%.  A  4  cm  ×  5  cm  left  ovarian  mass  was
emoved  uneventfully  in  40  min  with  minimal  blood  loss.  No
pisodes  of  hypoventilation  or  autonomic  instability  were
een.
Post-operatively  her  hemodynamics  were  stable  and  she
emained  calm.  We  prescribed  morphine  5  mg  QID  subcuta-
eously,  Tab  Paracetamol  1  g  QID  and  Tab  Celecoxib  200  mg
D  for  post-operative  analgesia.
A  week  after  surgery  she  remained  mostly  unrespon-
ive.  She  then  underwent  5  cycles  of  plasma  exchange.
istopathology  examination  of  the  excised  tumor  conﬁrmed
he  diagnosis  of  mature  cystic  teratoma.
One  week  after  plasma  exchange,  she  showed  marked
linical  improvement.  She  was  alert  and  talking  coherently.a  in  anti-N-methyl-d-aspartate  receptor  encephalitis  --  is
iol.  2016.  http://dx.doi.org/10.1016/j.bjane.2014.11.007
lthough  she  complained  of  occasional  visual  hallucinations,
he  had  an  excellent  functional  recovery  and  was  dis-
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questioning,  she  had  no  recollection  of  incidents  during  her
stay  and  speciﬁcally  could  not  recall  anything  about  the
operation.
Discussion
The  NMDA  receptor
NMDA  receptors  are  ionotropic  glutamate  receptors.  Eight
different  NR1,  four  NR2  and  two  NR3  subunits  have  been
identiﬁed.  The  NMDA  receptor  most  likely  consists  of  four
subunits,  with  at  least  one  NR1  and  one  NR2  subtype.5
The  receptor  controls  a  cation  channel  that  is  blocked
by  extracellular  Mg  at  resting  membrane  potential.6 Simul-
taneous  binding  of  glutamate  to  NR2  and  glycine,  the
coagonist,  to  NR1  is  required  for  receptor  activation.
Anti-NMDA  receptor  encephalitis
This  was  ﬁrst  described  by  J  Dalmau  and  colleagues,1 who
reported  a  case  series  of  100  patients,  mainly  young  women,
who  had  antibodies  against  NR-1  NR-2  heteromers.  All  pre-
sented  with  psychiatric  symptoms,  and  59%  had  tumors,
most  commonly  ovarian  teratoma.
A  prodromal  phase  of  headache,  fever,  or  upper  respi-
ratory  tract  symptoms  is  typically  followed  within  2  weeks
by  the  psychotic  phase,  characterized  by  mood  dysregula-
tion  and  severe  behavioral  disturbances.7,8 This  progresses
to  an  ‘unresponsive’  state,  in  which  periods  of  agitation
and  catatonia  can  alternate.  Of  interest  to  the  anes-
thetist  are  the  ﬁndings  of  autonomic  instability  during  this
stage,  including  hyperthermia,  tachycardia,  hypertension
and  bradycardia.  Some  patients  require  pacemakers  for
prolonged  cardiac  pauses.1 There  are  frequently  abnormal
movements,  increased  muscle  tone  and  dyskinesias.  Another
signiﬁcant  symptom  is  hypoventilation  of  central  origin.7,8
Many  patients  require  ventilation  in  the  intensive  care  unit.
Treatment  consists  of  immunotherapy  and  removal
of  tumor.  Corticosteroids,  intravenous  immunoglobulins,
plasma  exchange  or  drugs  such  as  rituximab  and  cyclophos-
phamide  have  been  used.  Patients  should  be  screened  for
an  underlying  tumor,  most  commonly  an  ovarian  teratoma.
Tumor  removal  resulted  in  substantial  improvement  in  80%
of  patients.8 Overall,  about  75%  of  patients  recover  or  have
mild  sequelae,  whereas  others  remain  severely  disabled  or
die.  The  estimated  mortality  is  4%.8
Anesthetic  considerations
Drugs  acting  at  the  NMDA  receptor
Many  anesthetic  drugs  act  at  the  NMDA  receptor.  NMDA
antagonists  include  ketamine,  phencyclidine,  nitrous  oxide
and  xenon.  Tramadol  and  methadone  act  both  at  opioid  and
NMDA  receptors.  These  drugs  may  cause  worsening  of  symp-
toms  and  should  be  avoided.
Halogenated  volatile  anesthetics  may  act  indirectly  atPlease  cite  this  article  in  press  as:  Chaw  SH,  et  al.  Anesthesi
general  anesthesia  a  requisite?  A  case  report.  Rev  Bras  Anestesi
the  NMDA  receptor  by  reducing  NMDA-activated  currents,
although  their  effects  on  GABAA receptors  may  be
dominant.9--11 Therefore  their  effects  may  be  unpredictable.






nd  sevoﬂurane,2,4 and  none  reported  increased  sensitivity
o  the  volatile  anesthetics.
Although  propofol  is  postulated  to  act  via  the  GABAA
eceptor  and  sodium  channel,  one  patient  had  unex-
ected  profound  hypotension  following  a  3  mg/kg  propofol
nduction.4 This  shows  that  NMDA  receptors  are  important
n  the  action  of  many  anesthetic  drugs.
ffects  of  the  disease
emperature  and  invasive  blood  pressure  monitoring  should
e  considered  as  many  patients  show  autonomic  instability.
ncreased  temperature  may  mimic  malignant  hyperthermia.
Central  hypoventilation  may  lead  to  difﬁculty  weaning,
r  to  unexpected  need  for  reintubation.  Patients  should  be
losely  monitored  in  a high  dependency  setting  following
eneral  anesthesia.  Prolonged  ventilation  increases  the  risks
f  ventilator  associated  pneumonias  and  may  necessitate  a
racheostomy.3
Abnormal  movements  and  dyskinesias  may  impede
atient  positioning  or  lead  to  nerve  injuries  and  difﬁcult
ntravenous  access.  Jaw  clenching  or  broken  teeth  may  lead
o  difﬁculties  during  intubation.
s  general  anesthesia  then  the  anesthetic  of  choice?
atients  with  anti-NMDA  receptor  encephalitis  are  likely  to
lready  have  a  reduced  perception  of  pain.12 Pain  involves
MDA  receptor  activation,  especially  the  NR2B  subunit.6,13
MDA  receptor  antagonists  are  potent  analgesics.  Periph-
ral  NMDA  receptor  antagonism  may  even  be  effective  in
reventing  visceral  pain.14 In  anti  NMDA  receptor  encephali-
is,  antibodies  target  the  extracellular  N-terminal  domain
f  the  NR1  subunit,  followed  by  antibody  mediated  capping
nd  internalization  of  NMDA  receptors.  This  leads  to  reduced
eceptor  density  and  NMDAR  mediated  currents.1,8,10 This
ay  be  why  patients  mimic  the  features  of  dissociative  anes-
hesia  produced  by  ketamine.
In  addition,  patients  are  unlikely  to  recall  intraoperative
vents  even  without  general  anesthesia.  Persisting  amne-
ia  of  the  entire  process  is  characteristic,  possibly  due  to
isruption  of  synaptic  plasticity.1
We  therefore  felt  that  a  TAP  block  would  be  sufﬁcient
s  the  sole  anesthetic  and  would  avoid  the  risks  associated
ith  general  anesthesia.  We  were  wary  of  a  central  neu-
axial  block  due  to  its  risks  in  recent  encephalitis,  possible
ncreased  intracranial  pressure  and  difﬁculty  positioning  an
ncooperative  patient.
The  block  succeeded  also  because  of  the  small  tumor  size
hat  enabled  the  surgeon  to  perform  a  quick  surgery  with
inimal  handling.
ransversus  abdominis  plane  block
his  is  an  abdominal  ﬁeld  block,  with  local  anesthetic
eposited  in  between  the  internal  oblique  and  transver-
us  abdominis  muscles  to  block  the  anterior  rami  of  spinal
erves  T7  to  L1  traversing  in  this  plane.  It  blocks  somatica  in  anti-N-methyl-d-aspartate  receptor  encephalitis  --  is
ol.  2016.  http://dx.doi.org/10.1016/j.bjane.2014.11.007
ensation  to  the  abdominal  skin,  muscles  and  parietal  peri-
oneum  but  not  visceral  sensation.15 Therefore  it  is  usually
sed  to  provide  analgesia  for  lower  abdominal  surgery,  and
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onclusion
e  present  a  case  of  a  patient  with  anti-NMDA  receptor
ncephalitis  who  underwent  laparotomy  and  cystectomy
ith  a  bilateral  TAP  block  as  the  sole  anesthetic.  The  anes-
hetic  considerations  are  highlighted.  Although  a  deﬁnite
onclusion  cannot  be  made  until  more  is  known  about  anti-
MDA  encephalitis  and  its  effect  on  pain  signaling,  we
ostulate  that  patients  have  an  altered  perception  to  pain.
his  may  contribute  to  the  feasibility  of  bilateral  TAP  block
s  the  sole  anesthetic  for  lower  abdominal  surgery  in  them
nd  would  also  avoid  the  risks  associated  with  a  general
nesthetic.
onsent
ritten  informed  consent  was  obtained  from  the  patient  for
ublication  of  this  case  report  and  accompanying  images.
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